A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China

被引:0
作者
Ningsheng Wang
Yue Chen
Biqi Ren
Yufang Xiang
Nan Zhao
Xianyan Zhan
Bianling Feng
机构
[1] Xi’an Jiaotong University,The Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy
[2] Xi’an Jiaotong University,The School of Public Health
[3] The First Affiliated Hospital of Xi’an Jiaotong University,undefined
来源
BMC Health Services Research | / 22卷
关键词
Adverse drug reaction; Pharmacovigilance; Knowledge, attitudes and practice; General public;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 169 条
[1]  
Pirmohamed M(1972)Report of a WHO meeting World Health Organization technical report series 498 1-25
[2]  
James S(2004)Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ 329 15-19
[3]  
Meakin S(2016)Drug safety: The concept, inception and its importance in patients' health Saudi Pharm J 24 405-412
[4]  
Green C(2015)Epidemiology of adverse drug reactions in Europe: a review of recent observational studies Drug Saf 38 437-453
[5]  
Scott AK(2018)Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria Pharmacovigilance in China: development and challenges 40 823-831
[6]  
Walley TJ(2019)Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature Int J Clin Pharm 41 1062-1073
[7]  
Alshammari TM(2018)ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems Eur J Clin Pharmacol 74 1235-1248
[8]  
Bouvy JC(2015)WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems Drug Saf 38 337-347
[9]  
De Bruin ML(2013)Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study Drug Saf 36 75-81
[10]  
Koopmanschap MA(2016)Causes for the underreporting of adverse drug events by health professionals: a systematic review Drug Saf 39 1189-1195